Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2025-12-27 @ 6:34 AM
Study NCT ID:
NCT04876092
Status:
COMPLETED
Last Update Posted:
2025-08-21
First Post:
2021-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
Sponsor:
Janssen Research & Development, LLC